Company Profile of JIANGSU COBEN PHARMACEUTICAL CO., LTD.

Founded in 1997, Coben Group was designed and built according to GMP standard. It is located in specialized chemical zone――Zhejiang Nanyang and Jiangsu Qidong with a total area of 110,000M2. Coben is specialized in developing and manufacturing of APIs and intermediates for anti-AIDS drugs, anti-cancer drugs, cardiovascular drugs, anti-inflammatory drugs, and advanced intermediates. Our main products include: Lamivudine, Tenofovir,Zidovudine, Abacavir, Emtricitabine, Losartan, Valsartan, Irbesartan, Eporlosartan, Clopidogrel, Gemcitabine,Carvedilol, Capecitabine, Loxoprofen, Etodolac, Tamsulosin and their intermediates. For cytosine, our annual output reaches 500MT, which is the largest among the world. Coben is one of the state hi-tech enterprises and provincial hi-tech enterprises, owning provincial R&D center. Most of the products are self-developed. We hold national and international patents for many product. Our factory is full equipped, including more than three hundred 50